Literature DB >> 18806338

Incidence, etiology, and antibiotic resistance patterns of gram-negative microorganisms isolated from patients with ventilator-associated pneumonia in a medical-surgical intensive care unit of a teaching hospital in istanbul, Turkey (2004-2006).

Ilknur Erdem1, Asu Ozgultekin, Asuman Sengoz Inan, Emine Dincer, Guldem Turan, Nurgul Ceran, Derya Ozturk Engin, Seniha Senbayrak Akcay, Nur Akgun, Pasa Goktas.   

Abstract

The identification of microorganisms causing ventilator-associated pneumonia (VAP) is important for formulating appropriate therapies. In this study, we report the incidence, etiology, and antibiotic resistance patterns of Gram-negative microorganisms isolated from patients diagnosed with VAP in our medical-surgical intensive care unit (ICU) during the years 2004-2006. VAP was diagnosed by using the clinical criteria of the Centers for Disease Control and Prevention. Antibiotic resistance patterns of isolated microorganisms were defined by standard methods. The VAP incidence rate was 22.6/1,000 ventilator days. The most frequently isolated pathogens were Acinetobacter spp., methicillin-resistant Staphylococcus aureus, and Pseudomonas aeruginosa. Ninety percent of Acinetobacter spp. isolates were resistant to ceftazidime, 64% to imipenem, and 80% to ciprofloxacin. Fifty-nine percent of P. aeruginosa isolates were resistant to ceftazidime, 32% to imipenem, and 62% to ciprofloxacin. Cefoperazone-sulbactam was the most active agent against Acinetobacter spp. In conclusion, the incidence of VAP and the prevalence of multidrug-resistant microorganisms are quite high in our ICU. Comparison of the resistance rates of isolates demonstrates that certain antibiotic agents are more effective than others.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18806338

Source DB:  PubMed          Journal:  Jpn J Infect Dis        ISSN: 1344-6304            Impact factor:   1.362


  10 in total

1.  Effectiveness of a multidimensional approach for prevention of ventilator-associated pneumonia in 11 adult intensive care units from 10 cities of Turkey: findings of the International Nosocomial Infection Control Consortium (INICC).

Authors:  H Leblebicioglu; A N Yalcin; V D Rosenthal; I Koksal; F Sirmatel; S Unal; H Turgut; D Ozdemir; G Ersoz; C Uzun; S Ulusoy; S Esen; F Ulger; A Dilek; H Yilmaz; O Turhan; N Gunay; E Gumus; O Dursun; G Yýlmaz; S Kaya; H Ulusoy; M Cengiz; L Yilmaz; G Yildirim; A Topeli; S Sacar; H Sungurtekin; D Uğurcan; M F Geyik; A Şahin; S Erdogan; A Kaya; N Kuyucu; B Arda; F Bacakoglu
Journal:  Infection       Date:  2013-01-26       Impact factor: 3.553

2.  Risk factors for acquisition of ventilator-associated pneumonia in adult intensive care units.

Authors:  Fariba Lahoorpour; Ali Delpisheh; Abdorrahim Afkhamzadeh
Journal:  Pak J Med Sci       Date:  2013-09       Impact factor: 1.088

3.  genetic determinants of intrinsic colistin tolerance in Acinetobacter baumannii.

Authors:  M Indriati Hood; Kyle W Becker; Christelle M Roux; Paul M Dunman; Eric P Skaar
Journal:  Infect Immun       Date:  2012-12-10       Impact factor: 3.441

4.  Loss of mitochondrial protein Fus1 augments host resistance to Acinetobacter baumannii infection.

Authors:  M Indriati Hood; Roman Uzhachenko; Kelli Boyd; Eric P Skaar; Alla V Ivanova
Journal:  Infect Immun       Date:  2013-09-16       Impact factor: 3.441

5.  Acinetobacter pneumonia: Is the outcome different from the pneumonias caused by other agents.

Authors:  Ebru Cakir Edis; Osman N Hatipoglu; Ozlem Tansel; Necdet Sut
Journal:  Ann Thorac Med       Date:  2010-04       Impact factor: 2.219

6.  Identification of an Acinetobacter baumannii zinc acquisition system that facilitates resistance to calprotectin-mediated zinc sequestration.

Authors:  M Indriati Hood; Brittany L Mortensen; Jessica L Moore; Yaofang Zhang; Thomas E Kehl-Fie; Norie Sugitani; Walter J Chazin; Richard M Caprioli; Eric P Skaar
Journal:  PLoS Pathog       Date:  2012-12-06       Impact factor: 6.823

7.  Analysis of the aetiology of diarrhoea in outpatients in 2007, Henan province, China.

Authors:  M Zhu; S Cui; L Lin; B Xu; J Zhao; S Xia; W Deng; Z Xie; J Zhang; Z Wang; Z Feng; W Yang; L Ran
Journal:  Epidemiol Infect       Date:  2012-06-07       Impact factor: 4.434

8.  Comparative activity of carbapenem testing (the COMPACT study) in Turkey.

Authors:  Hakan Leblebicioglu; Nedim Cakir; Mustafa Celen; Halil Kurt; Hakan Baris; Joerg Laeuffer
Journal:  BMC Infect Dis       Date:  2012-02-16       Impact factor: 3.090

9.  International Nosocomial Infection Control Consortium (INICC) national report on device-associated infection rates in 19 cities of Turkey, data summary for 2003-2012.

Authors:  Hakan Leblebicioglu; Nurettin Erben; Victor Daniel Rosenthal; Begüm Atasay; Ayse Erbay; Serhat Unal; Gunes Senol; Ayse Willke; Asu Özgültekin; Nilgün Altin; Mehmet Bakir; Oral Oncul; Gülden Ersöz; Davut Ozdemir; Ata Nevzat Yalcin; Halil Özdemir; Dinçer Yıldızdaş; Iftihar Koksal; Canan Aygun; Fatma Sirmatel; Alper Sener; Nazan Tuna; Özay Arikan Akan; Huseyin Turgut; A Pekcan Demiroz; Tanil Kendirli; Emine Alp; Cengiz Uzun; Sercan Ulusoy; Dilek Arman
Journal:  Ann Clin Microbiol Antimicrob       Date:  2014-11-18       Impact factor: 3.944

10.  Epidemiology and outcomes of ventilator-associated pneumonia in northern Brazil: an analytical descriptive prospective cohort study.

Authors:  Marília M Resende; Sílvio G Monteiro; Bianca Callegari; Patrícia M S Figueiredo; Cinara R A V Monteiro; Valério Monteiro-Neto
Journal:  BMC Infect Dis       Date:  2013-03-05       Impact factor: 3.090

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.